Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01322035 · ClinicalTrials.gov registry record
Erythrocyte and Adipocyte G6PD Activity Levels in Obesity
A clinical trial, sponsored by University of South Alabama.
- Completed
- Registry status
- 27
- Enrollment target
NCT01322035: Completed study, sponsored by University of South Alabama.
NCT01322035 is a clinical trial that has completed, run by University of South Alabama. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01322035 has completed, sponsored by University of South Alabama.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
This study compares the improvement of weight, fasting lipid profile (triglycerides, cholesterol, HDL, and LDL) and diabetes after gastric bypass surgery with an improvement in levels of an enzyme called glucose-6-phosphate dehydrogenase (G6PD).
Primary Outcome
G6PD levels will be measured various time intervals. G6PD is the rate limiting enzyme of the pentose phosphate pathway that provides NADPH required for lipid synthesis. G6PD overexpression is implicated in insulin resistance, hyperlipidemia and increases in oxidative stress.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2009-12 |
| Est. Completion | 2013-03 |
What the finished NCT01322035 record still lists
NCT01322035 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01322035 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01322035 about?
NCT01322035 is a clinical study titled "Erythrocyte and Adipocyte G6PD Activity Levels in Obesity". This study compares the improvement of weight, fasting lipid profile (triglycerides, cholesterol, HDL, and LDL) and diabetes after gastric bypass surgery with an improvement in levels of an enzyme called glucose-6-phosphate dehydrogenase (G6PD).
What is the current status of trial NCT01322035?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2009-12. Estimated completion is 2013-03.
Who is sponsoring clinical trial NCT01322035?
This trial is sponsored by University of South Alabama, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia